Your browser doesn't support javascript.
loading
ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion.
Gnosa, Sebastian P; Puig Blasco, Laia; Piotrowski, Krzysztof B; Freiberg, Marie L; Savickas, Simonas; Madsen, Daniel H; Auf dem Keller, Ulrich; Kronqvist, Pauliina; Kveiborg, Marie.
Afiliação
  • Gnosa SP; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Puig Blasco L; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Piotrowski KB; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Freiberg ML; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Savickas S; Department of Biotechnology and Biomedicine, Technical University of Denmark, Copenhagen, Denmark.
  • Madsen DH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Auf dem Keller U; Department of Biotechnology and Biomedicine, Technical University of Denmark, Copenhagen, Denmark.
  • Kronqvist P; Institute of Biomedicine and.
  • Kveiborg M; Department of Pathology, University of Turku, Turku, Finland.
JCI Insight ; 7(18)2022 09 22.
Article em En | MEDLINE | ID: mdl-35998057
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desintegrinas / Proteína ADAM17 / Macrófagos / Invasividade Neoplásica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desintegrinas / Proteína ADAM17 / Macrófagos / Invasividade Neoplásica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article